These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21488)

  • 21. [Influences of hypothalamus prolactin inhibiting factor and releasing factors and pineal gland on pituitary prolactin secreting functions (author's transl)].
    Takahashi K; Wada Y; Haneda A; Sakurada N; Saito K
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Sep; 32(9):1249-56. PubMed ID: 6113261
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prolactin. New findings and clinical significance].
    Horský J
    Cesk Gynekol; 1975 Mar; 40(2):148-53. PubMed ID: 805668
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hypophysiotropic factors, hypothalamus "hormone"].
    Smelik PG
    Ned Tijdschr Geneeskd; 1975 Aug; 119(32):1240-6. PubMed ID: 238160
    [No Abstract]   [Full Text] [Related]  

  • 24. Human prolactin: secretion, regulation and pathophysiology.
    Yuen BH; Keye WR; Jaffe RB
    Obstet Gynecol Surv; 1973 Aug; 28(8):527-41. PubMed ID: 4216868
    [No Abstract]   [Full Text] [Related]  

  • 25. Dopamine, PIF, and other regulators of prolactin secretion.
    Clemens JA; Shaar CJ; Smalstig EB
    Fed Proc; 1980 Sep; 39(11):2907-11. PubMed ID: 6105975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prolactin. Physiology and physiopathology].
    Hagen C; Frøland A
    Ugeskr Laeger; 1978 Feb; 140(6):275-80. PubMed ID: 24910
    [No Abstract]   [Full Text] [Related]  

  • 27. Prolactin release inhibiting and stimulating factors in the hypothalamus.
    Arimura A; Schally AV
    Adv Exp Med Biol; 1977; 87():237-52. PubMed ID: 19952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pathophysiology of hyperprolactinemic states and the role of newer ergot compounds in their treatment.
    Frantz AG; Kleinberg DL
    Fed Proc; 1978 Jun; 37(8):2192-7. PubMed ID: 26606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current knowledge on the biochemistry and function of hypothalamic hormones].
    Kolb E
    Z Gesamte Inn Med; 1983 Jul; 38(14):361-7. PubMed ID: 6139922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Thyrotropin-releasing factor (author's transl)].
    Adler G
    Postepy Biochem; 1977; 23(1):3-20. PubMed ID: 404635
    [No Abstract]   [Full Text] [Related]  

  • 31. Relation of the neuroendocrine system to the development and growth of experimental mammary tumors.
    Meites J
    J Neural Transm; 1980; 48(1):25-42. PubMed ID: 6106045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Old and new aspects of hypothalamic hormones: biochemical properties, biological actions, diagnostic and therapeutic applications].
    Mancinella A
    Clin Ter; 1980 Aug; 94(4):461-80. PubMed ID: 6109589
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hyperprolactinemic hypogonadism].
    Mel'nichenko GA; Kozlovskaia NL
    Sov Med; 1980; (9):70-4. PubMed ID: 6775376
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hypothalamic releasing and inhibiting hormones].
    Vanha-Perttula T
    Duodecim; 1973 Oct; 20(1):1282-98. PubMed ID: 4361282
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prolactin inhibiting factor (PIF) and prolactin releasing factor (PRF)].
    Kato Y; Osato K; Chihara K; Okanishi Y
    Horumon To Rinsho; 1975 Jan; 23(1):39-43. PubMed ID: 238775
    [No Abstract]   [Full Text] [Related]  

  • 36. Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.
    Scanlon MF; Pourmand M; McGregor AM; Rodriguez-Arnao MD; Hall K; Gomez-Pan A; Hall R
    J Endocrinol Invest; 1979; 2(3):307-31. PubMed ID: 231066
    [No Abstract]   [Full Text] [Related]  

  • 37. Calcitonin, prolactin, and growth hormone gene expression as model systems for the characterization of neuroendocrine regulation.
    Rosenfeld MG; Amara SG; Birnberg NC; Mermod JJ; Murdoch GH; Evans RM
    Recent Prog Horm Res; 1983; 39():305-51. PubMed ID: 6415768
    [No Abstract]   [Full Text] [Related]  

  • 38. Gonadotropic responsiveness to clomiphene, LRH, estradiol, and bromocriptine in galactorrheic women.
    Forsbach G; Soria J; Canales ES; Guzman V; Cabezas A; Zárate A
    Obstet Gynecol; 1977 Aug; 50(2):139-44. PubMed ID: 327363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human prolactin.
    Sherwood LM
    N Engl J Med; 1971 Apr; 284(14):774-7. PubMed ID: 4926708
    [No Abstract]   [Full Text] [Related]  

  • 40. Galactorrhea: clinical implications.
    Block MB
    Ariz Med; 1975 Feb; 32(2):111-3. PubMed ID: 805579
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.